Leverone Jason A. - Insider Non-Derivative Transactions at OnKure Therapeutics, Inc. (OKUR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 22, 2025, Leverone Jason A.'s relationship to OnKure Therapeutics, Inc. (OKUR) is Officer (Chief Financial Officer), and currently has 16,301 shares of Class A Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OKUR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Leverone Jason A. - Insider Non-Derivative Transactions of OKUR Class A Common Stock

Leverone Jason A. - Insider Non-Derivative Transactions at OKUR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 23, 2025	Sell -- (Class A Common Stock)	302	2.97	16301
Sep 23, 2025	Sell -- (Class A Common Stock)	303	2.62	12603
Jun 24, 2025	Sell -- (Class A Common Stock)	303	2.38	12906
Apr 8, 2025	Sell -- (Class A Common Stock)	1844	2.67	13209
Apr 5, 2025	Sell -- (Class A Common Stock)	1278	3.33	15053
Oct 5, 2024	Acquisition -- (Class A Common Stock)	16331	0	16331